Bitnomial launches Injective futures in the United States, potentially supporting the qualification for spot ETF applications

Mars Finance reports that, according to Cointelegraph, Chicago-based crypto derivatives exchange Bitnomial has launched Injective monthly futures contracts, marking Injective’s first entry into the regulated derivatives market in the United States. The contract is settled in INJ, expires monthly, and allows traders to gain price exposure without holding the underlying asset, with all cryptocurrencies or USD used as margin through Bitnomial. Institutional clients can trade this futures contract immediately, while retail trading is expected to open in the coming weeks via Bitnomial’s Botanical platform. Bitnomial also plans to add INJ perpetual futures and options. Analysts say that the launch of Injective futures contracts will initiate a six-month trading record, which could support applications for spot ETFs. Previously, Canary Capital submitted an INJ staking ETF application to the SEC.